Novo Nordisk A/S
Stable multi-dose compositions comprising an antibody and a preservative

Last updated:

Abstract:

The invention relates to stable, multi-dose liquid compositions containing proteins, in particular, but not exclusively stable antibodies, and to the use of said compositions in therapy, in particular for the subcutaneous delivery of said stable protein.

Status:
Grant
Type:

Utility

Filling date:

31 Oct 2017

Issue date:

17 Nov 2020